Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease by Adler, Jeremy et al.
ORIGINAL ARTICLE
Computed Tomography Enterography Findings Correlate with
Tissue Inﬂammation, Not Fibrosis in Resected Small Bowel
Crohn’s Disease
Jeremy Adler, MD, MSc,* Darashana R. Punglia, MD,† Jonathan R. Dillman, MD,‡
Alexandros D. Polydorides, MD, PhD,§ Maneesh Dave, MBBS, MPH,k Mahmoud M. Al-Hawary, MD,¶
Joel F. Platt, MD,¶ Barbara J. McKenna, MD,§ and Ellen M. Zimmermann, MD**
Background: It has become commonplace to categorize small intestinal Crohn’s disease (CD) as ‘‘active’’ vs. ‘‘inactive’’ or ‘‘inﬂammatory’’ vs.
‘‘ﬁbrotic’’ based on computed tomography enterography (CTE) ﬁndings. Data on histologic correlates of CTE ﬁndings are lacking. We aimed to
compare CTE ﬁndings with histology from surgically resected specimens. We tested the hypothesis that CTE ﬁndings can distinguish tissue
inﬂammation from ﬁbrosis.
Methods: Patients who underwent CTE within 3 months before intestinal resection for CD were retrospectively studied. Radiologists blinded to
history and histology scored ﬁndings on CTE. Pathologists blinded to history and imaging scored resected histology. We compared histology
with CTE ﬁndings and radiologists assessment of whether the stricture was likely ‘‘active’’ or ‘‘inactive.’’
Results: In all, 22 patients met inclusion criteria. Inﬂammatory CTE ﬁndings correlated with histologic inﬂammation (rho ¼ 0.52). Strictures
believed to be ‘‘active’’ on CTE were more inﬂamed at histology (P ¼ 0.0002). Strictures lacking inﬂammatory ﬁndings on CTE or considered
‘‘inactive’’ were not associated with greater histologic ﬁbrosis or signiﬁcant histologic inﬂammation. Upstream dilation was associated with
greater tissue ﬁbrosis in univariate (P ¼ 0.014) but not in multivariate analysis (P ¼ 0.53). Overall, histologic ﬁbrosis correlated best with histo-
logic inﬂammation (rho ¼ 0.52). Strictures on CTE with the most active disease activity also had the most ﬁbrosis on histology.
Conclusions: CTE ﬁndings of mesenteric hypervascularity, mucosal hyperenhancement, and mesenteric fat stranding predict tissue inﬂamma-
tion. However, small bowel stricture without CTE ﬁndings of inﬂammation does not predict the presence of tissue ﬁbrosis. Therefore, caution
should be used when using CTE criteria to predict the presence of scar tissue.
(Inﬂamm Bowel Dis 2012;18:849–856)
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C rohn’s disease (CD) is a condition of chronic, trans-mural bowel wall inﬂammation that can lead to lumi-
nal narrowing and stricture formation. The presence of an in-
testinal stricture can promote ﬁstula and abscess formation
proximal to the site of the stricture.1,2 Histologically, Crohn’s
strictures result from a combination of inﬂammation, smooth
muscle hyperplasia, and ﬁbrosis. In clinical practice, an intes-
tinal stricture that is predominantly inﬂammatory often
responds quickly to high-dose steroid therapy or therapy with
potent antitumor necrosis factor alpha (TNFa) agents. If an
intestinal stricture is primarily ﬁbrotic, it is not likely to
respond to antiinﬂammatory medical treatment. In patients
with obstructive symptoms a trial of an antiinﬂammatory
may relieve the intestinal obstruction, but exposes the patient
to the numerous potential side effects of therapy, including
deleterious effects of steroids on growth and development of
children.3–7 A stricture that does not respond to antiinﬂamma-
tory therapy is presumed to be ﬁbrotic and surgery is per-
formed. The preoperative trial of medical therapy can delay
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surgical therapy and may increase postoperative complica-
tions.8,9 Numerous studies have demonstrated the ability of a
variety of imaging modalities to predict disease activity10–14
and have attempted to distinguish between inﬂammatory and
ﬁbrotic strictures.15–19 However, to date no study has been
able to accurately characterize the presence of or assess the
degree of ﬁbrosis in an intestinal stricture.
Computed tomography enterography (CTE) is a dedi-
cated high-resolution CT examination with submillimeter
collimation and low-Hounsﬁeld unit oral contrast material
that is optimized for small bowel evaluation. Intravenous
and low Hounsﬁeld unit oral contrast materials are thought
to aid in distinguishing tissue types and, in particular, allow
for assessment of ﬁne details. Bowel wall inﬂammation is
presumed to be present when radiologic ﬁndings of inﬂam-
mation are present such as mucosal (or inner wall) hyper-
enhancement (including mural stratiﬁcation), mesenteric fat
stranding, and mesenteric hypervascularity (the so-called
‘‘comb sign’’).20 Bowel wall ﬁbrosis is presumed to be
present when a segment of bowel wall appears abnormally
thickened in the absence of radiologic signs of inﬂamma-
tion. CTE ﬁndings of mucosal hyperenhancement as well
as mesenteric hypervascularity correlate with the Crohn’s
disease activity index (CDAI),13,21,22 and inﬂammation
markers such as erythrocyte sedimentation rate (ESR) and
C-reactive protein (CRP).23,24 The converse is often
assumed to be true: luminal narrowing and wall thickening
without mesenteric hypervascularity and mucosal enhance-
ment in the setting of CD indicates a ﬁbrotic stricture. No
study has speciﬁcally tested the assumption that these CTE
ﬁndings, presumed to represent ﬁbrosis, actually correlate
with histologic ﬁndings of ﬁbrosis.25
We designed this study to retrospectively identify the
speciﬁc radiologic correlates of intestinal strictures using his-
tology as the reference standard. We tested the hypothesis
that CTE ﬁndings can distinguish between bowel wall inﬂam-
mation and ﬁbrosis in small intestinal strictures in CD.
PATIENTS AND METHODS
Patient Recruitment
Patients who underwent CTE examinations were identi-
ﬁed through the University of Michigan Health System
Department of Radiology adult and pediatric databases. Perti-
nent radiology reports and electronic medical records were
reviewed for patients who underwent CTE between January
2003 and October 2007. All patients with CD who underwent
surgical resection of a small bowel stricture for presumed CD
within a 3-month period after CTE were eligible for inclusion
in this study. Patients were excluded who were found to have
another pathologic process in the resected tissue such as con-
comitant neoplasm or endometriosis. Patients were also
excluded if tissue specimens were not available for review or
if data were otherwise incomplete.
CTE Review
Two abdominal radiologists who were blinded to both
the clinical history and to the pathologic ﬁndings retrospec-
tively reviewed all CT scans. The ﬁndings that were scored
included abnormal mucosal/mural enhancement, mesenteric
hypervascularity, and mesenteric inﬂammatory fat stranding.
Each of these CTE ﬁndings was graded on a Likert-like scale
from 0 to 3 (Table 1). Bowel wall thickening was scored
by categories of measured thickness (none [<3 mm], mild
[3–5 mm], moderate [5–7 mm], or marked thickening
[>7 mm]) (Fig. 1). Additional features were recorded includ-
ing narrowest luminal diameter of the stricture and diameter
of maximal upstream small bowel dilation.
A composite CTE inﬂammation score for each stricture
was deﬁned by the sum of scores for mucosal and mural
hyperenhancement, mesenteric hypervascularity, and mesen-
teric inﬂammatory fat stranding. The radiologists additionally
provided their global assessment of ileal inﬂammation (active
disease vs. abnormal, but likely inactive). Disease was con-
sidered ‘‘active’’ if an involved abnormal bowel segment had
mucosal hyperenhancement, mesenteric hypervascularity, and
mesenteric fat stranding; and ‘‘inactive’’ if an involved abnor-
mal bowel segment lacked these features.
Histologic Evaluation
Resected small bowel segments were retrieved and
reviewed. Formalin-ﬁxed, parafﬁn-embedded tissue sections
from the point of maximal involvement or narrowing were
stained with hematoxylin and eosin. Two gastrointestinal path-
ologists, blinded to the imaging ﬁndings, evaluated the resec-
tion specimens, scoring for degree of inﬂammation, degree
of ﬁbrosis, and the presence or absence of muscular
TABLE 1. CTE Evaluation Scoring
Feature 0 1 2 3
Abnormal mucosal/mural enhancement None Mild Mod Marked
Mesenteric hypervascularity None Mild Mod Marked
Mesenteric inﬂammatory stranding None Mild Mod Marked
Bowel wall thickening None(<3 mm) Mild (3-5 mm) Mod (5-7 mm) Marked (>7 mm)
Mod, moderate.
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hypertrophy (Table 2). The inﬂammation and ﬁbrosis scores
were adapted from histologic scores of small bowel CD previ-
ously published.26–28
Stricture Identification
In patients in whom multiple strictures were present,
close review of the operative note was performed to determine
if the stricture resected could be clearly identiﬁed on the CTE
examination. In the two cases where the exact stricture that
was resected could not be clearly determined, analysis was
performed with and without inclusion of those patients (see
Supporting Table 1).
Statistical Evaluation
Univariate comparisons were made with Spearman cor-
relation when ordinal scales were involved. Continuous varia-
bles were compared with Pearson correlations. Associations
between categorical variables were tested with a chi-square
test. Bivariate comparisons were made with two-tailed
Student’s t-test. Multivariate ordered logistic regression (olo-
git) was performed for multivariate analysis where the depend-
ent variable was an ordinal variable (such as tissue ﬁbrosis
score). Sex was represented as binary variable (1 ¼ female,
0 ¼ male). Duration of disease was represented in years from
diagnosis to CTE. Global assessment of stricture was repre-
sented as binary variable (1 ¼ ‘‘active disease,’’ 0 ¼ ‘‘abnormal,
but likely inactive’’). All statistical analyses were performed
with Stata 11.1 for Mac (StataCorp, College Station, TX).
Ethical Considerations
This study was approved by the Institutional Review
Board at the University of Michigan (IRB No. 2003-0306).
RESULTS
Of the 1387 patients who underwent CTE examina-
tions from January 2003 to October 2007, 28 patients had
CD and underwent surgery within 3 months after CTE (Fig.
2). Two patients were excluded due to either missing patho-
logic specimens or otherwise incomplete data. Of the remain-
ing 26 patients, four were excluded based on the presence of
neoplasm, lipoma, or endometriosis in their resected small
bowel specimen. (The patient with lipoma had insufﬁcient
nonlipomatous tissue resected to be diagnostic.) The remain-
ing 22 patients were included in the CTE-pathologic correla-
tion portion of this study (Table 3). Of these 22 patients, 11
underwent resection for small bowel obstruction. Seven were
described in the medical record as having medical refractory
CD and four had surgery for ﬁstulizing disease (although
only three had mention of ﬁstulas on the operative reports).
Seven patients had more than one small bowel stricture pres-
ent. In ﬁve of those patients the stricture that was resected
FIGURE 1. CTE ﬁndings. Illustrations of speciﬁc CTE ﬁndings. Bowel
wall inﬂammation is seen as mucosal hyperenhancement, mesen-
teric hypervascularity (A), and mesenteric fat stranding (B). The
ﬁnding of bowel wall thickening (B) and luminal narrowing in the
absence of inﬂammatory ﬁndings has previously been felt to repre-
sent ﬁbrosis.
TABLE 2. Histologic Evaluation Scoring
Fibrosis Grades
0 No ﬁbrosis
1 Minimal ﬁbrosis in submucosa or subserosa
2 Increased submucosal ﬁbrosis, septa into
muscularis propria
3 Septa through muscularis propria, increase
in subserosal collagen
4 Signiﬁcant transmural scar, marked subserosal collagen
Inﬂammation Grades
0 No inﬂammation or distortion
1 Lamina propria inﬂammation only
2 Submucosal foci of inﬂammation
3 Foci of transmural inﬂammation
4 Signiﬁcant, dissecting, conﬂuent transmural inﬂammation
Muscle
0 Normal thickness
1 Increased thickness of muscularis propria layer
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could be clearly identiﬁed in the operative report. In two
patients the exact stricture resected could not be determined
with certainty (Supporting Table 1).
The composite CTE radiologic inﬂammation score
correlated well with the degree of histologic tissue inﬂam-
mation (n ¼ 22; rho ¼ 0.52; P ¼ 0.014; Fig. 3). Individual
CTE features that make up the components of the CTE
inﬂammation score correlated as well, including mucosal
hyperenhancement (rho ¼ 0.89; P < 0.0001), mesenteric
hypervascularity (rho ¼ 0.91; P < 0.0001), adjacent
inﬂammatory fat stranding (rho ¼ 0.82; P < 0.0001), and
wall thickening (rho ¼ 0.83; P < 0.0001). The composite
CTE radiologic inﬂammation score correlated with the
degree of histologic tissue ﬁbrosis (n ¼ 22; rho ¼ 0.48;
P ¼ 0.023). These results did not change when the two
patients with uncertain location of stricture resection were
excluded from analysis (see Supporting Addendum).
The various CTE ﬁndings traditionally associated with
bowel wall inﬂammation including mucosal hyperenhance-
ment, bowel wall thickening, mesenteric hypervascularity, and
adjacent mesenteric fat stranding each were found to increase
with increasing degrees of inﬂammation in the corresponding
resected tissue specimen (Fig. 4A). However, such a pattern
was less apparent when comparing radiologic ﬁndings with
degree of tissue ﬁbrosis in resected specimens (Fig. 4B).
The presence of upstream dilation was associated
with higher ﬁbrotic content (histologic ﬁbrosis score
3.69 6 0.17 vs. 2.56 6 0.44; P ¼ 0.014) and with some-
what higher, although not statistically signiﬁcant, inﬂam-
matory content (histologic inﬂammation score 3.23 6 0.20
vs. 2.22 6 0.56; P ¼ 0.063) in resected specimens




Mean age at CTE, mean (SD), years 33.4 (13.5)
<18 (n¼3) 13.9 (1.8)
18-30 (n¼7) 26.0 (3.3)
31-40 (n¼7) 34.9 (3.4)
>40 (n¼5) 53.2 (7.0)
Duration of disease at CTE, mean (SD), years 10.5 (11.6)
<5 (n¼9) 1.8 (1.2)
5-10 (n¼6) 6.9 (1.4)
10-20 (n¼2) 14.4 (5.1)
>20 (n¼5) 28.7 (8.8)
Surgery type, number (%)
Ileocecectomy 18 (81.8%)
Ileocolectomy 1 (4.6%)
Distal ileal resection* 3 (13.6%)
Para-stomal ﬁstula 1 (4.8%)
Entero-enteric ﬁstula resection 1 (4.8%)
Entero-fallopian tube ﬁstula 1 (4.8%)
Ileo-sigmoid ﬁstula 1 (4.8%)
Indication for surgery, number (%)
Small bowel obstruction 11 (50.0%)
Medical refractory therapy 7 (31.8%)
Fistulizing disease 4 (18.2%)
Anastomotic stricture 1 (4.8%)
*All three patients with distal ileal resection had history of prior
ileocecectomy.
FIGURE 3. Composite CTE inﬂammation score correlates well with
histologic score for tissue inﬂammation (rho ¼ 0.52; P ¼ 0.014).
[Color ﬁgure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
FIGURE 2. Consort diagram.
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compared with those with the absence of appreciable
upstream dilation (Fig. 5A). Neither the measured diameter
of upstream dilation (v2 ¼ 26.82; P ¼ 0.22) nor the tissue
thickness (v2 ¼ 22.43; P ¼ 0.097) of the stricture on CTE
correlated with ﬁbrotic content of the resected tissue.
When the radiologists global impression indicated
‘‘active disease’’ in the stricture, the corresponding tissue
samples were found to have a greater degree of inﬂamma-
tion (n ¼ 17; histologic inﬂammation score 3.29 6 0.19)
than those strictures felt to be ‘‘abnormal, but likely inac-
tive disease’’ (n ¼ 5; histologic inﬂammation score 1.20 6
0.58; P ¼ 0.0002). Those strictures felt to represent ‘‘active
disease’’ also had a higher degree of tissue ﬁbrosis than
those felt to be ‘‘abnormal, but likely inactive’’ (n ¼ 22;
3.65 6 0.17 vs. 1.80 6 0.49; P ¼ 0.0002) (Fig. 5B). Those
strictures felt to represent ‘‘inactive disease’’ were associ-
ated with the least tissue ﬁbrosis.
When histologic tissue inﬂammation and ﬁbrosis were
compared with one another, all specimens that were more
ﬁbrotic were also found to be more inﬂamed. Those that
were less ﬁbrotic were also less inﬂamed. There were no
ﬁbrotic specimens that were not inﬂamed, and no inﬂamed
specimens that were not ﬁbrotic (Table 4). The degree of tis-
sue inﬂammation correlates best with the degree of tissue ﬁ-
brosis (n ¼ 22; rho ¼ 0.52; P ¼ 0.014; Fig. 6).
Ordered logistic regression was performed with radio-
logic ﬁndings (mucosa/mural enhancement, mesenteric
hypervascularity, mesenteric inﬂammatory stranding, bowel
wall thickening, upstream dilation [presence or absence],
duration of disease, and sex) as independent variables, and
histologic tissue ﬁbrosis score as the ordinal dependent
FIGURE 4. Radiologic ﬁndings associated with inﬂammation in
stricture including mucosal hyperenhancement, mesenteric hyper-
vascularity, inﬂammatory fat stranding, and bowel wall thickness
are compared with degree of histologic tissue inﬂammation (A)
and tissue ﬁbrosis (B). Note that all radiologic scoring features
increase as degree of tissue inﬂammation increases. However,
radiologic scoring features do not follow a consistent pattern with
increasing tissue ﬁbrosis. [Color ﬁgure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
FIGURE 5. Resected stricture tissue histologic ﬁndings were com-
pared in patients with and without upstream dilation on CTE (A)
and between patients with and without active disease identiﬁed in
the stricture on CTE (B). Patients with upstream dilation had
greater tissue ﬁbrosis (3.69 6 0.17 vs. 2.56 6 0.44; P ¼ 0.014) and
inﬂammation (3.23 6 0.20 vs. 2.22 6 0.56; P ¼ 0.063) in resected
specimens than those without upstream dilation. Patients in whom
the radiologists global impression was that the stricture was ‘active’
the highest degree of tissue ﬁbrosis (3.65 6 0.17 vs. 1.80 6 0.49;
P ¼ 0.0002) and inﬂammation (3.29 6 0.19 vs. 1.20 6 0.58; P ¼
0.0002) compared with strictures described as ‘not active.’ [Color
ﬁgure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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variable. The results with and without considering interac-
tion terms are represented in Table 5. Hyperenhancement is
positively associated with a tendency toward greater tissue
ﬁbrosis. For a one unit increase in degree of postcontrast
enhancement, the expected ordered odds increases by 8.52 as
you move to the next higher category of ﬁbrosis (for exam-
ple, from minimal submucosal ﬁbrosis to increased submu-
cosal ﬁbrosis). Mesenteric hypervascularity is negatively
associated with a tendency toward greater tissue ﬁbrosis. For
a one unit increase in mesenteric hypervascularity, the
expected ordered log odds decreases by 9.96 as you move to
the next higher category of tissue ﬁbrosis. Mesenteric inﬂam-
matory fat stranding is positively associated with tissue ﬁbro-
sis, with a one unit increase being associated with a tendency
toward greater tissue ﬁbrosis category (ordered log odds
5.93). There was no statistically signiﬁcant effect of bowel
wall thickening, upstream dilation, duration of disease, or sex
on tissue ﬁbrosis. The adjusted pseudo R2 of 0.5740 (P ¼
0.0002) indicates that 57.4% of the variability in tissue ﬁbrosis
score is explained by this model. Predicted probabilities for
transmural ﬁbrotic scar found in the resected specimen based
on mesenteric hypervascularity are represented in Supporting
Figure 1 (also see Supporting Table 2). All analyses were
repeated with the exclusion of the two patients with whom
ambiguity existed regarding precisely which stricture was
resected. The results of these analyses were not signiﬁcantly
different to the above ﬁndings (Supporting Table 3).
DISCUSSION
CTE provides exquisitely detailed images of the small
bowel. Numerous studies have demonstrated the ability of
CTE to detect small bowel disease activity in patients with
CD, and CTE ﬁndings have been shown to correlate with se-
rologic markers of inﬂammation.23,24 CTE ﬁndings also cor-
relate with endoscopic disease activity.23,29–31
However, the general assumptions that are commonly
made regarding the tissue composition of small intestinal
strictures due to CD based on CTE ﬁndings have not been
validated.25 In this study we demonstrated that the CTE ﬁnd-
ings of bowel wall inﬂammation do, in fact, indicate the
presence of tissue inﬂammation. However, we did not ﬁnd a
strong correlation between the radiologic ﬁndings presumed
to be suggestive of ﬁbrosis and the presence of histologic ﬁ-
brosis. In fact, the only feature on CTE that predicted the
presence of small bowel ﬁbrosis in multivariate analysis was
mesenteric hypervascularity. Mesenteric hypervascularity
itself correlates better with the presence of tissue inﬂamma-
tion than with tissue ﬁbrosis. This appears to be due to, at
least in part, the pathologic relationship between inﬂamma-
tion and ﬁbrosis. Histologic inﬂammation and ﬁbrosis are
strongly correlated with one another, and do not appear to be
separable entities. Our ﬁndings agree with the ﬁndings of
Zappa et al,32 who previously raised the issue that inﬂamma-
tion and ﬁbrosis in CD are inseparably linked. It is in fact
likely that CTE cannot assess the presence of ﬁbrosis with or
without associated inﬂammation because ﬁbrosis and inﬂam-
mation do not exist as mutually exclusive stricture types.
This study was limited by a relatively small sample
size. However, the range of abnormal features in the CTE
examinations in this series is typical of the spectrum of
FIGURE 6. Histologic score for inﬂammation and ﬁbrosis correlate
with one another in resected tissue samples (rho ¼ 0.52; P ¼
0.014). Note data points were subject to jitter(7) in Stata for ease
of visualization. [Color ﬁgure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]












Minimal submucoslal ﬁbrosis 2 1 0 0 0 3
Increased submucosal ﬁbrosis 0 0 0 1 1 2
Septa through muscularis 0 0 1 3* 0 4
Transmural scar 0 0 3* 3 7 13
Total 2 1 4 7 8 22
*One patient in each category had uncertain location of resection.
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abnormalities seen in our clinical practice.21 Our sample
also lacked purely ﬁbrotic strictures and the most ﬁbrotic
strictures also had signiﬁcant inﬂammation. It is possible
that CD patients with ﬁbrotic strictures with no inﬂamma-
tion exist, but our experience and that of others would sug-
gest that this is likely very rare.32 Ideally, CTE would have
been performed on the same day or the day prior to surgi-
cal resection, but for practical reasons we chose to study
patients with CTE within 3 months of resection. The length
of time from CTE to surgery allows for the possibility of
intervening worsening of disease or change in the histo-
logic tissue composition. However, bowel wall ﬁbrosis, if
reversible, would not be expected to regress signiﬁcantly in
this time frame, and if anything might progress. Therefore,
our results may underrepresent the degree of ﬁbrosis present
at the later time of surgery, not overrepresent the differen-
ces. Finally, it is possible that CTE could be better able to
distinguish between inﬂammation and ﬁbrosis in less ﬁbrotic
bowel. However, patients with lesser degrees of ﬁbrosis
would not be expected to undergo surgical resection, and
therefore would not be included as part of this study. Our
study design is not able to address this question.
Despite these limitations, this is the largest study to
date investigating the relationship between ﬁndings on
CTE of patients with CD and the corresponding histologic
ﬁndings in resected specimens from the same patients. Our
data support that the CTE ﬁndings of mucosal hyperen-
hancement, mesenteric hypervascularity, and adjacent
inﬂammatory fat stranding correlate with the degree of tis-
sue inﬂammation in resected specimens. However, bowel
wall thickening without inﬂammatory signs does not appear
to be a useful predictor of tissue ﬁbrosis.
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